We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
19.00 | 1.07% | 1,799.50 | 1,796.00 | 1,796.50 | 1,799.50 | 1,780.00 | 1,784.00 | 9,804,173 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.00 | 73.94B |
TIDMGSK
RNS Number : 8076G
GlaxoSmithKline PLC
27 November 2020
GlaxoSmithKline plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for 2021:
Results Announcement Ex-dividend Record date Last date for Payable date date DRIP elections Q1 2021 Wednesday 28 Thursday 20 Friday 21 Thursday 8 April 2021 May 2021 May 2021 Thursday 17 July 2021 June 2021 --------------- --------------- --------------- ------------------- -------------- Q2 2021 Wednesday 28 Thursday 19 Friday 20 Thursday 16 Thursday 7 July 2021 August 2021 August 2021 September 2021 October 2021 --------------- --------------- --------------- ------------------- -------------- Q3 2021 Wednesday 27 Thursday 18 Friday 19 Monday 20 December Thursday 13 October 2021 November 2021 November 2021 2021 January 2022 --------------- --------------- --------------- ------------------- -------------- Q4 2021 Wednesday 9 Thursday 24 Friday 25 Thursday 17 Thursday 7 February 2022 February 2022 February 2022 March 2022 April 2022 (Final) --------------- --------------- --------------- ------------------- --------------
These dates are indicative and may be subject to change.
V A Whyte
Company Secretary
27 November 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFLFESLRLDFII
(END) Dow Jones Newswires
November 27, 2020 09:58 ET (14:58 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions